BioTrove and SPRI Expand Lead Discovery Collaboration
News Dec 07, 2005
As part of the ongoing relationship, BioTrove will use its proprietary RapidFire® Lead Discovery service for assay development and high throughput screening on an undisclosed number of targets identified by Schering-Plough.
RapidFire Lead Discovery is a mass spectrometry-based technology that enables the high throughput screening of biochemical assays.
The system can analyze assays by mass spectrometry at throughputs of four to eight seconds per sample.
"With RapidFire our collaborators have been able to pursue many drug targets that were previously inaccessible due to technical or economical difficulties," said Can "Jon" Ozbal, Ph.D., Director of the RapidFire program.
"The ability of RapidFire to perform direct mass spectrometric quantification of native substrates and products facilitates very fast assay development by eliminating the need to synthesize and validate surrogate substrates or antibodies for conventional optical assays," he added.
"We are pleased with the expansion of our ongoing relationship with Schering-Plough."
"The growing level of interest and novel findings from our pharmaceutical partners validates our unique position in the area of high throughput screening," said Alan Carter, Chief of Commercial Operations.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Evidence of Drinking Water Contamination from FrackingNews
A study of drinking water in Appalachian Ohio found no evidence of natural gas contamination from recent oil and gas drilling.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018